News & Events

Latest Press Releases

• 

  NIH-funded study suggests that testosterone suppresses brain tumor growth in males

  • May 6, 2026

  In a new National Institutes of Health (NIH)-funded study, scientists at Cleveland Clinic discovered that hormones associated with male development may play a key role in limiting the growth of brain tumors in men. The research team found that the loss of androgen hormones, such as testosterone, in a preclinical model of glioblastoma drove tumor growth by inducing local inflammation and triggering the production of stress hormones.

• 

  NIH-funded AI model predicts cancer survival from single-cell tumor data

  • April 21, 2026

  In a National Institutes of Health (NIH)-funded study, researchers developed a cancer assessment tool that can identify high-risk patients and the tumor cells linked to that risk. The model, called scSurvival, uses a machine learning framework designed to analyze large-scale data at single-cell resolution.

• 

  Chronic inflammation leaves long-lasting impression on gut stem cells, increasing colorectal cancer risk

  • March 25, 2026

  In a new study, funded in part by the National Institutes of Health (NIH), researchers have uncovered a molecular mechanism that could explain how chronic gut inflammation may increase the risk of colorectal cancer. By simulating chronic colitis in mice and tracking the colon’s response during inflammation and recovery, scientists demonstrated that these changes increased the activity of a specific group of proteins, AP-1 transcription factors, and promoted tumor growth.

• 

  Researchers identify new blood markers that may detect early pancreatic cancer

  • January 30, 2026

  National Institutes of Health (NIH)-supported investigators have developed a blood test to find pancreatic ductal adenocarcinoma, one of the deadliest forms of cancer. The new test could improve survival rates from pancreatic cancer, which tends to be diagnosed at late stages when therapy is less likely to be effective. The findings were published in Clinical Cancer Research.

• 

  NIH-led study reveals role of mobile DNA elements in lung cancer progression

  • December 10, 2025

  Using lung cancer biospecimens from the Sherlock-Lung study, an international team led by National Institutes of Health (NIH) researchers, identified key factors that drive tumor evolution and influence outcomes. Overall, the findings, published Dec. 10, 2025, in Nature, describe a previously unknown origin of some aggressive lung cancers.